CrisPRO Blog

Insights, news, and research at the intersection of AI and oncology.

Mechanisms of Cancer Immunity and Cancer-related Autoimmunity - Abstract Submission

Featured Article

Mechanisms of Cancer Immunity and Cancer-related Autoimmunity - Abstract Submission

From automated variant interpretation to in silico therapeutic validation

Case Study in Action: Predicting Radiotherapy Response with TP53

July 08, 2025

Case Study in Action: Predicting Radiotherapy Response with TP53

Why do some patients respond well to radiation therapy, while others don't?

Pillar 6: The Triumvirate Checkpoint

June 28, 2025

Pillar 6: The Triumvirate Checkpoint

Seventh pillar of CrisPRO platform, a testament to our commitment to reliability.

Operational Directive: Annihilation of Cancer of Unknown Primary (CUP)

June 28, 2025

Operational Directive: Annihilation of Cancer of Unknown Primary (CUP)

Cancer of unknown primary (CUP) means that cancer spread has been found in your body (secondary cancer), but your doctors can't find where the cancer started.

Metastasis Isn't Fate. It's a Kill Chain. And We've Cracked the Code.

June 26, 2025

Metastasis Isn't Fate. It's a Kill Chain. And We've Cracked the Code.

Metastasis is what kills. It's responsible for an estimatedĀ 90% of all cancer-related deaths

Introducing the CrisPRO Oncology Co-Pilot

December 04, 2024

Introducing the CrisPRO Oncology Co-Pilot

Our mission to empower clinicians with smarter tools, to accelerate the discovery and development of life-saving therapies for researchers, and to offer patients a more personalized, connected, and hopeful journey.